A first in Canada, implementing the BD HealthSight™
combines timely surveillance to support the early detection of
emerging healthcare infections to provide patients with the right
care at the right time.
ST.
JOHN'S, NL, June 22,
2022 /CNW/ - BD (Becton, Dickinson and Company)
(NYSE: BDX), a leading global medical technology company, is
pleased to announce the integration of the BD HealthSight™
Analytics Solutions in Eastern Health facilities. Eastern Health
will become the first healthcare authority in Canada to integrate BD HealthSight™, which
aims to reduce the use of antibiotics and other medications in
addition to helping healthcare providers identify emerging
infections among patients.
"At Eastern Health, our priority is to provide safe, quality
care for our patients and clients. We are continually exploring
innovative opportunities to enhance care," said Ron Johnson, Vice President of Innovation and
Rural Health, Eastern Health. "Since announcing our strategic
innovation partnership with BD, we are pleased to move forward to
test this IT solution which could help our clinicians better
identify potential infections, and potentially result in improved
outcomes for our patients and provide a better patient experience
for those we serve."
Eastern Health and BD formally launched their innovation
partnership in late 2021 and have been working together to improve
clinical outcomes for patients by implementing innovative solutions
for healthcare professionals. This solution is at the core of a
broader collaborative program between BD and Eastern Health,
focusing on connected medication management and extending infection
prevention and antimicrobial stewardship programs.
Adapting to changing patient conditions, BD HealthSight™
Clinical Advisor and Infection Advisor are connected healthcare
solutions that can help identify patients at risk of developing
emerging infections. Automatic system alerts inform clinicians who
are taking care of the medication management of patients and help
them to avoid waste and create better treatment outcomes for
patients.
Antimicrobial stewardship programs are designed to optimize
antibiotic therapies to help slow the emergence of drug resistance.
Accurate and rapid diagnostic testing is crucial to
identifying the infection-causing organism, determining whether it
is resistant and guiding the appropriate therapeutic choice. BD
HealthSight™ leverages data to produce meaningful analytics and
insights for hospitals and the scientific community to help drive
stewardship efforts forward.
"Antimicrobial resistance is a global health problem associated
with increasing deaths and cost of care in Canada," said Dr. Peter Daley, Associate Professor of Medicine at
Memorial University. "Antimicrobial
resistance is caused by inappropriate antimicrobial use, which
occurs more often in Newfoundland
and Labrador than in other
provinces. Work is ongoing in the province to enhance the
understanding of appropriate antimicrobial use among prescribers
and patients, and technological solutions may be effective in
improving antimicrobial stewardship."
"This marks an important expansion of our partnership with
Eastern Health to support patients and the healthcare system of
Newfoundland and Labrador," said Ivy
Parks, President BD-Canada.
"Generating timely insights to protect healthcare systems against
infectious disease trends and their unintended consequences will be
key. The implementation of HealthSight offers a much-needed
solution in supporting the right care at the right time."
About BD
BD is one of the largest global medical technology companies in
the world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of healthcare by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for
healthcare providers. BD and its 70,000 employees have a passion
and commitment to help enhance the safety and efficiency of
clinicians' care delivery process, enable laboratory scientists to
accurately detect disease and advance researchers' capabilities to
develop the next generation of diagnostics and therapeutics. BD has
a presence in virtually every country and partners with
organizations around the world to address some of the most
challenging global health issues. By working in close collaboration
with customers, BD can help enhance outcomes, lower costs, increase
efficiencies, improve safety and expand access to healthcare. For
more information on BD, please visit bd.com/en-ca or connect with
us on LinkedIn at https://www.linkedin.com/company/bd1/ and
Twitter @BDandCo.
About Eastern
Health
Eastern Health is the largest, integrated health authority in
Newfoundland and Labrador employing approximately 13,000
dedicated employees, over 700 medical staff, and is supported by
approximately 2,000 volunteers, including members of numerous
auxiliaries and fundraising foundations. With an annual budget of
approximately $1.6 billion, the
authority offers the full continuum of health and community
services including public health, long-term care, community
services, hospital care and unique provincial programs and
services. Serving a population of over 300,000, Eastern Health's
geographic boundaries extend west from St. John's to Port
Blandford including all communities on the Avalon, Burin and
Bonavista Peninsulas.
SOURCE BD - Canada